Position in MBX
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$64,462,504
+$29,592,451 QoQ
Shares Held
1,167,799
-0.0% QoQ
Ownership
2.42%
of shares outstanding
% of Portfolio
5.11%
of 13F equity value
Holder Rank
#12
of 171 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MBX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aaron Wealth Advisors LLC holds $73,154,083 across 15 Biotechnology names. MBX ranks #1 (88.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MBX |
MBX Biosciences, Inc.
This page
|
1,167,799 | $64,462,504 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,021 | $2,494,081 | |
| 3 | MNKD |
Mannkind Corp
|
234,948 | $1,000,878 | |
| 4 | ARGX |
Argenx SE
|
943 | $874,887 | |
| 5 | KURA |
Kura Oncology, Inc.
|
67,455 | $739,981 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
944 | $588,621 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
2,411 | $580,978 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
2,670 | $500,037 |
All Filings in MBX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,462,504 | 1,167,799 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $34,870,053 | 1,168,176 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $2,207,800 | 70,000 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $875,000 | 50,000 | Shares | Sole | 2025-10-03 | |
| 2025-06-30 | $570,500 | 50,000 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $369,000 | 50,000 | Shares | Sole | 2025-04-28 | |
| No filing history on record for this holder in this stock. | ||||||